These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 3298412

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
    Anderson MG, Harrison TJ, Alexander GJ, Zuckerman AJ, Murray-Lyon IM.
    J Hepatol; 1986; 3 Suppl 2():S225-7. PubMed ID: 3298409
    [Abstract] [Full Text] [Related]

  • 4. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A, Fattovich G, Pontisso P, Brollo L, Belussi F, Ruol A.
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis.
    Schalm SW, Heytink RA, Van Buuren HR, De Man RA.
    J Hepatol; 1986 Dec; 3 Suppl 2():S189-92. PubMed ID: 3598156
    [Abstract] [Full Text] [Related]

  • 7. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
    Barbara L, Mazzella G, Baraldini M, Gasbarrini G, Giungi F, Malavolti M, Mastroroberto L, Miglio F, Roda E, Raise E.
    J Hepatol; 1986 Dec; 3 Suppl 2():S235-8. PubMed ID: 3298411
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Different doses of recombinant alpha interferon in the treatment of chronic hepatitis B patients without antibodies against the human immunodeficiency virus.
    Porres JC, Carreño V, Mora I, Gutiez J, Moreno A, Ramon y Cajal S, Marron JA, Bartolomé J.
    Hepatogastroenterology; 1988 Dec; 35(6):300-3. PubMed ID: 3215626
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interferon therapy of chronic hepatitis B virus infection in Chinese.
    Lok AS, Lai CL, Wu PC.
    J Hepatol; 1986 Dec; 3 Suppl 2():S209-15. PubMed ID: 3036936
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients.
    Alexander GJ, Fagan EA, Guarner P, Rolando N, Brahm J, Eddleston AL, Williams R.
    J Hepatol; 1986 Dec; 3 Suppl 2():S183-8. PubMed ID: 3298406
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.